Comparative pharmacology of a new recombinant FSH expressed by a human cell line

Recombinant FSH proteins are important therapeutic agents for the treatment of infertility, including follitropin alfa expressed in Chinese Hamster Ovary (CHO) cells and, more recently, follitropin delta expressed in the human cell line PER.C6. These recombinant FSH proteins have distinct glycosylat...

Full description

Bibliographic Details
Main Authors: Wolfgang Koechling, Daniel Plaksin, Glenn E Croston, Janni V Jeppesen, Kirsten T Macklon, Claus Yding Andersen
Format: Article
Language:English
Published: Bioscientifica 2017-07-01
Series:Endocrine Connections
Subjects:
Online Access:http://www.endocrineconnections.com/content/6/5/297.full
_version_ 1819057827721773056
author Wolfgang Koechling
Daniel Plaksin
Glenn E Croston
Janni V Jeppesen
Kirsten T Macklon
Claus Yding Andersen
author_facet Wolfgang Koechling
Daniel Plaksin
Glenn E Croston
Janni V Jeppesen
Kirsten T Macklon
Claus Yding Andersen
author_sort Wolfgang Koechling
collection DOAJ
description Recombinant FSH proteins are important therapeutic agents for the treatment of infertility, including follitropin alfa expressed in Chinese Hamster Ovary (CHO) cells and, more recently, follitropin delta expressed in the human cell line PER.C6. These recombinant FSH proteins have distinct glycosylation, and have distinct pharmacokinetic and pharmacodynamic profiles in women. Comparative experiments demonstrated that follitropin delta and follitropin alfa displayed the same in vitro potency at the human FSH receptor, but varied in their pharmacokinetics in mouse and rat. While follitropin delta clearance from serum depended in part on the hepatic asialoglycoprotein receptor (ASGPR), follitropin alfa clearance was unaffected by ASGPR inhibition in rat or genetic ablation in mice. The distinct properties of follitropin delta and follitropin alfa are likely to contribute to the differing pharmacokinetic and pharmacodynamic profiles observed in women and to influence their efficacy in therapeutic protocols for the treatment of infertility.
first_indexed 2024-12-21T13:45:30Z
format Article
id doaj.art-694a90018c9e49529fd82a9cf92d9a66
institution Directory Open Access Journal
issn 2049-3614
2049-3614
language English
last_indexed 2024-12-21T13:45:30Z
publishDate 2017-07-01
publisher Bioscientifica
record_format Article
series Endocrine Connections
spelling doaj.art-694a90018c9e49529fd82a9cf92d9a662022-12-21T19:01:53ZengBioscientificaEndocrine Connections2049-36142049-36142017-07-016529730510.1530/EC-17-0067Comparative pharmacology of a new recombinant FSH expressed by a human cell lineWolfgang Koechling0Daniel Plaksin1Glenn E Croston2Janni V Jeppesen3Kirsten T Macklon4Claus Yding Andersen5Ferring Pharmaceuticals A/S, Copenhagen, DenmarkBio-Technology General Israel Ltd, Ferring Pharmaceuticals, Kiryat Malachi, IsraelCroston Consulting, San Diego, California, USAThe Laboratory of Reproductive Biology, The Department of Fertility at The Juliane Marie Centre, Rigshospitalet, Copenhagen University Hospital and The University of Copenhagen, Copenhagen, DenmarkThe Laboratory of Reproductive Biology, The Department of Fertility at The Juliane Marie Centre, Rigshospitalet, Copenhagen University Hospital and The University of Copenhagen, Copenhagen, DenmarkThe Laboratory of Reproductive Biology, The Department of Fertility at The Juliane Marie Centre, Rigshospitalet, Copenhagen University Hospital and The University of Copenhagen, Copenhagen, DenmarkRecombinant FSH proteins are important therapeutic agents for the treatment of infertility, including follitropin alfa expressed in Chinese Hamster Ovary (CHO) cells and, more recently, follitropin delta expressed in the human cell line PER.C6. These recombinant FSH proteins have distinct glycosylation, and have distinct pharmacokinetic and pharmacodynamic profiles in women. Comparative experiments demonstrated that follitropin delta and follitropin alfa displayed the same in vitro potency at the human FSH receptor, but varied in their pharmacokinetics in mouse and rat. While follitropin delta clearance from serum depended in part on the hepatic asialoglycoprotein receptor (ASGPR), follitropin alfa clearance was unaffected by ASGPR inhibition in rat or genetic ablation in mice. The distinct properties of follitropin delta and follitropin alfa are likely to contribute to the differing pharmacokinetic and pharmacodynamic profiles observed in women and to influence their efficacy in therapeutic protocols for the treatment of infertility.http://www.endocrineconnections.com/content/6/5/297.fullfollicle-stimulating hormonefollitropin deltagonadotropin clearancerecombinant FSHFSH glycosylation
spellingShingle Wolfgang Koechling
Daniel Plaksin
Glenn E Croston
Janni V Jeppesen
Kirsten T Macklon
Claus Yding Andersen
Comparative pharmacology of a new recombinant FSH expressed by a human cell line
Endocrine Connections
follicle-stimulating hormone
follitropin delta
gonadotropin clearance
recombinant FSH
FSH glycosylation
title Comparative pharmacology of a new recombinant FSH expressed by a human cell line
title_full Comparative pharmacology of a new recombinant FSH expressed by a human cell line
title_fullStr Comparative pharmacology of a new recombinant FSH expressed by a human cell line
title_full_unstemmed Comparative pharmacology of a new recombinant FSH expressed by a human cell line
title_short Comparative pharmacology of a new recombinant FSH expressed by a human cell line
title_sort comparative pharmacology of a new recombinant fsh expressed by a human cell line
topic follicle-stimulating hormone
follitropin delta
gonadotropin clearance
recombinant FSH
FSH glycosylation
url http://www.endocrineconnections.com/content/6/5/297.full
work_keys_str_mv AT wolfgangkoechling comparativepharmacologyofanewrecombinantfshexpressedbyahumancellline
AT danielplaksin comparativepharmacologyofanewrecombinantfshexpressedbyahumancellline
AT glennecroston comparativepharmacologyofanewrecombinantfshexpressedbyahumancellline
AT jannivjeppesen comparativepharmacologyofanewrecombinantfshexpressedbyahumancellline
AT kirstentmacklon comparativepharmacologyofanewrecombinantfshexpressedbyahumancellline
AT clausydingandersen comparativepharmacologyofanewrecombinantfshexpressedbyahumancellline